• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: April 19-23, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

April 19-23, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/22/10Washington, DCJesse Goodman, Ralph Tyler, Michael Chappell, Stephen Sundlof, Meghan Scott, Kanya Balakrishna, several FDA employeesN/ASpeech at Food and Drug Law Institute (FDLI) Annual Conference
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs4/23/10Washington, DCMeghan Scott, Kanya BalakrishnaN/ASpeech at United States Pharmaceutical Convention
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs4/19/10Washington, DCJeanne IrelandStephen Cha, Sarah Despres, Rachel Sher, Eric Flamm (Staff of Congressman Henry A. Waxman)Antimicrobial Resistance
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs4/20/10Washington, DCN/AN/ACongressional Black Caucus Spring Health Braintrust/National Minority Quality Forum: Working Together to Achieve Health Equity
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine4/22/10TeleconferenceWilliam FlynnJohn Clifford (USDA)Animal Drug Issues
Beth Martino, Associate Commissioner for External Affairs4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/19/10Bethesda, MDStephen Wilson, Robert O'Neill, Ram Tiwari, Mary Parks Joachim Vollmar (International Clinical Development Consultants, LLC); Barry Schwab (Johnson & Johnson Pharmaceutical Research and Development, LLC); Christy Chuang-Stein (Statistical Research and Consulting Center, Pfizer Inc.); Armin Koch (Institute of Biometry Hanover Medical School, Germany)4th Annual FDA/DIA Statistics Forum Integrating Knowledge in Clinical Development: Meta-analysis, Non-Inferiority, and Related Topics
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research4/23/10Rockville, MDTheresa Mullin, John Jenkins, Robert Temple, Mary Parks, Patricia Keegan, Debra BirnkrantSonya Dougal (The New York Academy of Sciences); Alasdair Breckenridge (Medicines and Healthcare Products Regulatory Agency, UK); Robyn Lim (Health Canada); Larry Phillips (London School of Economics); John Ferguson (Novartis Vaccines & Diagnostic)Risk Benefit Consideration in Drug Regulatory Decision-Making 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods4/20/10Las Vegas, NVSharon Natanblut, Jim GornyUnited Fresh Board of DirectorsProduce Safety
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods4/20/10Las Vegas, NVSharon Natanblut, Jim GornyMichael Spinazzola (Diversified Restaurant Systems, Inc./Subway)Food Safety
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs4/22/10Washington, DCN/AGigi Hirsch (MIT Center for Biomedical Innovation); Tom Unger (Pfizer Biotherapeutics & Bioinnovation Center); Badhri Srinivasan (Quintiles)International Issues
Ralph Tyler, J.D., Chief Counsel4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
Russell Abbott, Deputy Commissioner for Administration4/20/10Rockville, MDN/AIsiah Leggett, Melanie Wegner, and Steve Silveman (Office of the County Executive for Montgomery County), and several Chief Executives from Various Business Organizations for Montgomery CountyPresentation of Items of Mutual Interest by Montgomery County
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition4/19/10-4/23/10N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research4/19/10-4/23/10N/AN/AN/ANo Significant Meetings